Osteoprotegerin is More than a Possible Serum Marker in Liver Fibrosis: A Study into its Function in Human and Murine Liver
Osteoprotegerin (OPG) serum levels are associated with liver fibrogenesis and have been proposed as a biomarker for diagnosis. However, the source and role of OPG in liver fibrosis are unknown, as is the question of whether OPG expression responds to treatment. Therefore, we aimed to elucidate the f...
Main Authors: | Adhyatmika Adhyatmika, Leonie Beljaars, Kurnia S. S. Putri, Habibie Habibie, Carian E. Boorsma, Catharina Reker-Smit, Theerut Luangmonkong, Burak Guney, Axel Haak, Keri A. Mangnus, Eduard Post, Klaas Poelstra, Kim Adhyatmika, Peter Olinga, Barbro N. Melgert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/5/471 |
Similar Items
-
The elusive antifibrotic macrophage
by: Adhyatmika eAdhyatmika, et al.
Published: (2015-11-01) -
Targeted therapies in liver fibrosis: combining the best parts of platelet derived growth factor BB and interferon gamma
by: Fransien van Dijk, et al.
Published: (2015-10-01) -
Régulation de l'expression du gène de l'ostéoprotégérine dans les cellules ostéosarcomateuses MG-63
by: Lambert, Cecile
Published: (2008) -
Plasma Osteoprotegerin Levels Before and After Treatment of Thyroid Dysfunctions
by: Didem Özdemir, et al.
Published: (2013-12-01) -
Osteoprotegerin is a new marker of cardiovascular diseases
by: A F Verbovoy, et al.
Published: (2017-04-01)